Search

Animal model research from MSK has shown for the first time that fasting can reprogram the metabolism of natural killer cells, helping them to survive in the harsh environment in and around tumors, while also improving their cancer-fighting ability.

… Friday, June 14, 2024 Periods of fasting reprogram the immune system’s natural killer cells to better fight cancer, according to a new study in mice from researchers at Memorial Sloan Kettering Cancer Center (MSK). Fasting and other dietary regimens are increasingly being explored as ways to starve cancer

Doctors are developing treatment strategies that target the androgen receptor, which is found in many triple-negative breast cancers.

… Monday, January 29, 2018 Summary Doctors at MSK are at the forefront of developing treatment strategies that target the androgen receptor. This hormone drives the growth of many triple-negative breast cancers. For many people with breast cancer , drugs that target proteins driving the cancer’s growth

Ten scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 15, 2024, as part of Memorial Sloan Kettering’s 45th annual academic convocation.

… Monday, May 13, 2024 On May 15, 2024, 10 newly minted PhD scientists will officially be granted their degrees from the  Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK)  . The graduates will receive their diplomas as part of the 45th annual academic convocation and commencement ceremony

Scientists are looking to exploit defects in DNA repair as an Achilles’ heel in cancer.

… Friday, December 9, 2016 Summary Mistakes in DNA repair can lead to cancer. But they also present opportunities for treatment. Today at the San Antonio Breast Cancer Symposium, MSK Radiation Oncology Chair Simon Powell discusses new DNA repair–targeting treatments coming down the pipeline. Thousands

At any given time, close to 700 teenagers and young adults are in active treatment at Memorial Sloan Kettering. On March 18, MSK opened a hip new space dubbed the Lounge as part of the newly launched Teen and Young Adult Program designed to give these young patients the support they need during a turbulent time.

… Tuesday, March 22, 2016 Summary At any given time, close to 700 teenagers and young adults are in active treatment at Memorial Sloan Kettering. On March 18, MSK opened a hip new space dubbed the Lounge as part of the newly launched Teen and Young Adult Program designed to give patients 16-28 years of

MSK was recently in the news regarding our relationship with a technology spin-off company called Paige.AI.

… Sunday, September 23, 2018 MSK was recently in the news regarding our relationship with a technology spin-off company called Paige.AI. The MSK board and leadership believe that this pioneering work has the potential to improve the diagnosis and care of cancer patients around the world. MSK is proud to

MSK achieved status as a Magnet®-recognized organization, an esteemed honor for nursing excellence.

… Wednesday, February 17, 2016 Summary The American Nurses Credentialing Center granted Magnet recognition ® to MSK today, a prestigious honor given to institutions that demonstrate nursing excellence. This achievement confirms the superb performance of the entire nursing staff and marks the culmination

Find out how to handle feelings of self-blame and shame that may accompany a cancer diagnosis.

… Wednesday, October 9, 2019 Summary Many people experience self-blame around a cancer diagnosis, and some may even experience feelings of embarrassment or shame. There are ways around that, says MSK social worker Kristie Redfield. Having cancer is difficult. Adding feelings of guilt, shame, or embarrassment

Worry and confusion around COVID-19 are common in the general population, but cancer patients are also balancing concern over what the pandemic means for their treatment, prognosis, and vulnerability to the virus.

… Tuesday, May 5, 2020 Worry and confusion around COVID-19 are common in the general population, but cancer patients are also balancing concern over what the pandemic means for their treatment, prognosis, and vulnerability to the virus. Doctors and nurses at Memorial Sloan Kettering (MSK) shared their

A study by Memorial Sloan Kettering (MSK) recently published in JAMA Oncology showed that radiation dose to the elective regions can be safely de-escalated for patients with human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) who received concurrent chemotherapy.

… Thursday, March 10, 2022 A study by Memorial Sloan Kettering (MSK) recently published in JAMA Oncology   (1) showed that radiation dose to the elective regions can be safely de-escalated for patients with human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) who received concurrent chemotherapy